AtriCure to test clip for stroke prevention in AFib patients; Paragonix pursues 510(k) for heart transport device;

@FierceMedDev: Study: Medtronic next-gen pacer tech achieves atrial fibrillation delay. More | Follow @FierceMedDev

@MarkHFierce: Cardiovascular Systems wants to sell 2.1M shares in a public offering. Simply put: expansion requires funding. Story | Follow @MarkHFierce

@MichaelGFierce: Spoke to MIT's Dr. Robert Langer about drug delivery and nanotech. Story in tomorrow's FierceDrugDelivery report. | Follow @MichaelGFierce

> AtriCure won FDA approval to begin testing its AtriClip device to prevent strokes in patients with atrial fibrillation. Item

> VeriTeQ, a maker of implantable medical devices for identification and radiation dose measurement, has changed its ticker symbol from "DIGAD" to "VTEQ." Item

> TriReme Medical in California said that its Japanese partner, Century Medical, won regulatory approval in Japan for its GliderXtreme PTA catheter to treat peripheral arterial blockages.  Item

> Canada's Klox Technologies now has CE mark approval to market its topical photo-converter gel to treat acne vulgaris, a severe form of acne. Item

> Paragonix Technologies has completed a second 510(k) application with the FDA for its device designed for static hypothermic preservation of hearts for transport and eventual transplantation. Item

Biotech News

@FierceBiotech: Gilead charts PhIII success for leukemia drug as J&J showdown awaits. More | Follow @FierceBiotech

@JohnCFierce: Check out my webinar Thursday morning with Toni Ribas and Carol Gallagher on targeted cancer drugs. More | Follow @JohnCFierce

@DamianFierce: AstraZeneca just can't wait to get to Cambridge, plans to deploy 400 scientists to get R&D ball rolling. Story | Follow @DamianFierce

@EmilyMFierce: As resistance rises, one MIT team is investigating how a bacteria-derived toxin could help design new antibiotics. Article | Follow @EmilyMFierce

> Merck spotlights promising data on 'breakthrough' cancer immunotherapy MK-3475. More

> Amgen's cancer-fighting virus boosts melanoma survival in PhIII study. Article

Pharma News

@FiercePharma: Monday's most-read story: Takeda's new outsider CFO charged with $1B cost-cutting plan. More | Follow @FiercePharma

@EricPFierce: Patheon, DSM join forces in $2.6B deal, to create no name company with global reach. More | Follow @EricPFierce

@CarlyHFierce: U.S. approves drug tracking, compound pharmacy oversight law. Story from FiercePharmaManufacturing | Follow @CarlyHFierce

> One certainty: Drug spending will hit $1 trillion in 2014. Story

> EMA: No new safety flags in Roche's stash of unreported side effects. Report

> Philly jury hits J&J with $11M verdict in Topamax birth-defects case. Article

Pharma Manufacturing News

> Glaxo to use new technology in India plant. Report

> 2 Puerto Rico plants up next in Merck job-whacking plan. Story

> J&J, Merck KGaA roll out new China plant projects. Article

> DSM, Patheon join up in $2.6B deal. More

> U.S. approves drug tracking, compound pharmacy oversight law. Story

> Mylan recalls 480,000 bottles of blood pressure med. Item

Biotech Research News

> Tekmira's RNAi antivirals protect animals from lethal doses of Ebola, Marburg. More

> Oxford, MRC Technology team up on migraine drug discovery. Item

> First-ever 'mini-kidney' organs created from human stem cells. Story

> Bacteria-derived toxin could provide design for new antibiotics. Article

> Herb-based compounds improve learning, memory in Alzheimer's mice. News

> Compound that targets fat-burning mechanism discovered. Report

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.